Remicade and Hair loss - a phase IV clinical study of FDA data

Summary:

We study 215,158 people who have side effects when taking Remicade. Hair loss is found, especially among people who are female, 40-49 old, have been taking the drug for < 1 month, also take Enbrel and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people take Remicade and have Hair loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 20, 2023

215,158 people reported to have side effects when taking Remicade.
Among them, 12,381 people (5.75%) have Hair loss.

What is Remicade?

Remicade has active ingredients of infliximab. It is used in crohn's disease. Currently, eHealthMe is studying from 216,502 Remicade users.

What is Hair loss?

Hair loss is found to be associated with 3,510 drugs and 3,391 conditions by eHealthMe. Currently, we are studying 258,060 people who have Hair loss.

Number of Remicade and Hair loss reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Hair loss?

Check whether Hair loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

Related studies

Remicade side effects by duration, gender and age:

Remicade side effects (216,502 reports)

Hair loss treatments and more:

Hair loss (258,060 reports)

Common drugs associated with Hair loss:

All the drugs that are associated with Hair loss:

Hair loss (3,510 drugs)

Common conditions associated with Hair loss:

Rheumatoid arthritis: 21,741 reports
Multiple sclerosis: 14,215 reports
Breast cancer: 11,443 reports
Chemotherapy: 8,910 reports
High blood pressure: 5,484 reports

All the conditions that are associated with Hair loss:

Hair loss (3,391 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.